Interferon-free therapy with direct acting antivirals for HCV/HIV-1 co-infected Japanese patients with inherited bleeding disorders.
Haruka UemuraKunihisa TsukadaDaisuke MizushimaTakahiro AokiKoji WatanabeEi KinaiKatsuji TeruyaHiroyuki GatanagaYoshimi KikuchiMasaya SugiyamaMasashi MizokamiShinichi OkaPublished in: PloS one (2017)
DAA therapy is effective in all patients. However, adverse events and efficacy of cART should be monitored closely.
Keyphrases
- end stage renal disease
- hepatitis c virus
- human immunodeficiency virus
- ejection fraction
- chronic kidney disease
- newly diagnosed
- prognostic factors
- antiretroviral therapy
- hiv infected
- peritoneal dialysis
- hiv positive
- atrial fibrillation
- dendritic cells
- hiv aids
- stem cells
- hiv testing
- patient reported outcomes
- mesenchymal stem cells
- south africa
- men who have sex with men
- smoking cessation
- patient reported